DE69329274T2 - Hämatologisches Kontrollprodukt mit Leukozytenanalogen; und Methoden zu ihrer Herstellung und Anwendung - Google Patents

Hämatologisches Kontrollprodukt mit Leukozytenanalogen; und Methoden zu ihrer Herstellung und Anwendung

Info

Publication number
DE69329274T2
DE69329274T2 DE69329274T DE69329274T DE69329274T2 DE 69329274 T2 DE69329274 T2 DE 69329274T2 DE 69329274 T DE69329274 T DE 69329274T DE 69329274 T DE69329274 T DE 69329274T DE 69329274 T2 DE69329274 T2 DE 69329274T2
Authority
DE
Germany
Prior art keywords
cell
control product
leukocyte
analogs
making
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69329274T
Other languages
English (en)
Other versions
DE69329274D1 (de
Inventor
Carole Young
N Elliott
J Fischer
R Naylor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beckman Coulter Inc
Original Assignee
Coulter Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Coulter Corp filed Critical Coulter Corp
Publication of DE69329274D1 publication Critical patent/DE69329274D1/de
Application granted granted Critical
Publication of DE69329274T2 publication Critical patent/DE69329274T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material
    • G01N2496/05—Reference solutions for assays of biological material containing blood cells or plasma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/101666—Particle count or volume standard or control [e.g., platelet count standards, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/102499—Blood gas standard or control
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/105831—Protein or peptide standard or control [e.g., hemoglobin, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/106664—Blood serum or blood plasma standard or control
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/107497—Preparation composition [e.g., lysing or precipitation, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331—Preservative, buffer, anticoagulant or diluent
DE69329274T 1992-02-24 1993-02-17 Hämatologisches Kontrollprodukt mit Leukozytenanalogen; und Methoden zu ihrer Herstellung und Anwendung Expired - Lifetime DE69329274T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84043592A 1992-02-24 1992-02-24
PCT/US1993/001855 WO1993017330A1 (en) 1992-02-24 1993-02-17 Hematology control composition for leukocyte analogs; and methods for their preparation and use

Publications (2)

Publication Number Publication Date
DE69329274D1 DE69329274D1 (de) 2000-09-28
DE69329274T2 true DE69329274T2 (de) 2001-04-12

Family

ID=25282374

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69329274T Expired - Lifetime DE69329274T2 (de) 1992-02-24 1993-02-17 Hämatologisches Kontrollprodukt mit Leukozytenanalogen; und Methoden zu ihrer Herstellung und Anwendung

Country Status (11)

Country Link
US (2) US5320964A (de)
EP (1) EP0628167B1 (de)
JP (1) JP3391451B2 (de)
KR (1) KR950700539A (de)
AT (1) ATE195810T1 (de)
AU (1) AU665413B2 (de)
BR (1) BR9305952A (de)
CA (1) CA2129832A1 (de)
DE (1) DE69329274T2 (de)
NO (1) NO943115L (de)
WO (1) WO1993017330A1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270208A (en) * 1991-05-09 1993-12-14 Streck Laboratories, Inc. White blood cell hematology control
DE69329274T2 (de) * 1992-02-24 2001-04-12 Coulter Corp Hämatologisches Kontrollprodukt mit Leukozytenanalogen; und Methoden zu ihrer Herstellung und Anwendung
US6362003B1 (en) * 1992-02-24 2002-03-26 Coulter Corporation Hematological reference control composition containing leukocyte analogs, methods of making, and uses thereof
US6509192B1 (en) * 1992-02-24 2003-01-21 Coulter International Corp. Quality control method
US5631165A (en) * 1994-08-01 1997-05-20 Abbott Laboratories Method for performing automated hematology and cytometry analysis
US5656499A (en) * 1994-08-01 1997-08-12 Abbott Laboratories Method for performing automated hematology and cytometry analysis
US5891734A (en) * 1994-08-01 1999-04-06 Abbott Laboratories Method for performing automated analysis
WO1996012181A1 (en) * 1994-10-12 1996-04-25 Research & Diagnostics Systems, Inc. Reticulocyte assay control
WO1996034291A1 (en) * 1995-04-28 1996-10-31 Coulter International Corp. Quality control method of hematology instruments
US5858790A (en) 1996-06-26 1999-01-12 Abbott Laboratories Hematology reference control and method of preparation
US6146901A (en) * 1997-06-16 2000-11-14 Hematronix, Inc. Composition for manipulating optical and electrical properties of particles to achieve target values for such properties and methods for using the composition
US5994139A (en) * 1998-04-07 1999-11-30 Coulter International Corp. Stable hematology control composition and method of use
US6221668B1 (en) 1999-08-20 2001-04-24 Streck Laboratories, Inc. Hematology control and system for multi-parameter hematology measurements
US6200500B1 (en) 1999-08-20 2001-03-13 Streck Laboratories, Inc. Hematology control and system for multi-parameter hematology measurements
US6444471B1 (en) 1999-10-18 2002-09-03 Research & Diagnostic Systems, Inc. Reticulocyte containing complete blood control
AU2001275421A1 (en) * 2000-06-12 2001-12-24 Hematronix, Inc. Hematology composition using preserved white blood cells
US6653063B2 (en) 2000-06-12 2003-11-25 Hematronix, Inc. Hematology composition using preserved white blood cells in combination with source particles to simulate native white blood cells and method of making same
US6569682B2 (en) * 2001-07-27 2003-05-27 Coulter International Corp. Hematology control product with increased closed vial stability
EP1442305B1 (de) * 2001-10-16 2009-09-30 Kode Biotech Limited Aus modifizierten zellen präparierte empfindlichkeitskontrollen für blutserologie
US6759246B1 (en) * 2001-11-30 2004-07-06 Research & Diagnostic Systems, Inc. Hematology control composition including lymphocyte analogs and method for preparation and use
US6723563B2 (en) 2001-12-03 2004-04-20 Streck Laboratories Inc. Hematology reference control
US6653137B2 (en) 2001-12-03 2003-11-25 Streck Laboratories Inc. Hematology reference control
EP1422509A1 (de) * 2002-11-01 2004-05-26 Streck Laboratories, Inc. Lysierungsreagenz und Verfahren zum Lysieren von Roten Blutkörperchen für die Hämatologie
US6962817B2 (en) * 2003-10-02 2005-11-08 Beckman Coulter, Inc. Reference control for optical measurement of nucleated red blood cells of a blood sample
US7198953B2 (en) * 2003-10-12 2007-04-03 Beckman Coulter, Inc. Method of using a reference control composition for measurement of nucleated red blood cells
US7195919B2 (en) * 2003-12-19 2007-03-27 Beckman Coulter, Inc. Hematology controls for reticulocytes and nucleated red blood cells
EP1738163A4 (de) * 2004-04-07 2008-01-23 Beckman Coulter Inc Referenzkontrolle mit einer kernhaltigen roten blutzellkomponente
US7109036B2 (en) * 2004-05-13 2006-09-19 Beckman Coulter, Inc. Hematology reference control containing an immature granulocyte component
US7354767B2 (en) * 2006-03-16 2008-04-08 Beckman Coulter, Inc. Reference control composition containing a nucleated red blood cell component made of non-nucleated blood cells
CN101535804B (zh) * 2006-11-14 2013-04-24 贝克曼考尔特公司 血液学线性对照组合物、体系和使用方法
US7618821B2 (en) * 2007-04-13 2009-11-17 Streck, Inc. Simulated blood components and methods
CN101311724B (zh) * 2007-05-24 2014-11-12 深圳迈瑞生物医疗电子股份有限公司 单群白细胞模拟离子、包含单群白细胞模拟离子的校准物及其制备方法
CN101311725B (zh) * 2007-05-25 2014-03-26 深圳迈瑞生物医疗电子股份有限公司 一种五分类白细胞质控物及其制备方法
CN101561443B (zh) * 2008-04-15 2013-08-21 深圳迈瑞生物医疗电子股份有限公司 五分类白细胞模拟物粒子、其制备方法以及含该模拟粒子的质控物和校准物
US20100086962A1 (en) 2008-10-08 2010-04-08 Streck, Inc. Hematology controls and methods
CN101887059B (zh) * 2009-05-11 2014-03-19 深圳迈瑞生物医疗电子股份有限公司 嗜酸性粒细胞模拟物、制备方法及全血质控物
CN102109430B (zh) 2009-12-25 2013-11-06 深圳迈瑞生物医疗电子股份有限公司 有核红细胞模拟粒子，血液质控物及其制备方法和用途
JP6117181B2 (ja) * 2011-04-28 2017-04-19 ベックマン コールター， インコーポレイテッド 長期の安定性を有する血液学用コントロール組成物
CA2998829A1 (en) 2015-09-17 2017-03-23 S.D. Sight Diagnostics Ltd Methods and apparatus for detecting an entity in a bodily sample
US11307196B2 (en) 2016-05-11 2022-04-19 S.D. Sight Diagnostics Ltd. Sample carrier for optical measurements
EP3491381A1 (de) 2016-07-29 2019-06-05 Streck, Inc. Suspensionszusammensetzung zur kontrolle einer hämatologischen analyse
JP7214729B2 (ja) 2017-11-14 2023-01-30 エス．ディー．サイト ダイアグノスティクス リミテッド 光学測定用試料収容器
CN111366737A (zh) * 2018-12-26 2020-07-03 深圳市帝迈生物技术有限公司 血细胞分析仪用质控物及其制备方法、血细胞分析仪

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2656508A (en) * 1949-08-27 1953-10-20 Wallace H Coulter Means for counting particles suspended in a fluid
US3502974A (en) * 1966-05-23 1970-03-24 Coulter Electronics Signal modulated apparatus for generating and detecting resistive and reactive changes in a modulated current path for particle classification and analysis
US3741875A (en) * 1970-10-30 1973-06-26 Mount Sinai Res Foundation Inc Process and apparatus for obtaining a differential white blood cell count
BE790042A (nl) * 1971-10-14 1973-04-13 Coulter Electronics Werkwijze voor het classifiseren van deeltjes
US3873467A (en) * 1974-02-01 1975-03-25 United Medical Lab Inc Hematologic reference control
US4219440A (en) * 1979-06-06 1980-08-26 Coulter Electronics, Inc. Multiple analysis hematology reference control reagent and method of making the same
US4358394A (en) * 1979-05-07 1982-11-09 Coulter Electronics, Inc. Process for preparing whole blood reference controls having long term stability
US4299726A (en) * 1979-05-07 1981-11-10 Coulter Electronics, Inc. Process for preparing whole blood reference controls having long term stability, preconditioning diluent and media therefor
US4324686A (en) * 1979-06-11 1982-04-13 R & D Systems, Inc. Hematology control composition and methods for its use
US4436821A (en) * 1982-04-12 1984-03-13 Streck Laboratories, Inc. Simulated human platelets from red blood cells
US4485175A (en) * 1983-01-03 1984-11-27 Coulter Electronics, Inc. Method for three-volume differential determination of lymphocyte, monocyte and granulocyte populations of leukocytes
US4579824A (en) * 1983-05-18 1986-04-01 Louderback Allan Lee Hematology control
US4745074A (en) * 1984-02-23 1988-05-17 Cooper-Lipotech Partnership Blood-fluid composition for cell lysis system
US4704364A (en) * 1984-05-18 1987-11-03 Coulter Electronics, Inc. Hematology control compositions for three populations of leukocytes; and methods for their preparation and use in whole blood control systems
US4751179A (en) * 1984-05-31 1988-06-14 Coulter Electronics, Inc. Method and reagents for differential determination of four populations of leukocytes in blood
US4777139A (en) * 1987-06-25 1988-10-11 Fisher Scientific Company Hematology control or calibrator with red cell components of enhanced stability
US5008201A (en) * 1990-05-24 1991-04-16 Streck Laboratories, Inc. Simulated human platelets from red blood cells
DE69329274T2 (de) * 1992-02-24 2001-04-12 Coulter Corp Hämatologisches Kontrollprodukt mit Leukozytenanalogen; und Methoden zu ihrer Herstellung und Anwendung

Also Published As

Publication number Publication date
DE69329274D1 (de) 2000-09-28
EP0628167A1 (de) 1994-12-14
BR9305952A (pt) 1997-10-21
ATE195810T1 (de) 2000-09-15
US5320964A (en) 1994-06-14
AU665413B2 (en) 1996-01-04
AU3736693A (en) 1993-09-13
EP0628167A4 (de) 1996-10-30
JPH07504038A (ja) 1995-04-27
NO943115L (no) 1994-09-01
EP0628167B1 (de) 2000-08-23
JP3391451B2 (ja) 2003-03-31
KR950700539A (ko) 1995-01-16
WO1993017330A1 (en) 1993-09-02
NO943115D0 (no) 1994-08-23
CA2129832A1 (en) 1993-08-25
US5512485A (en) 1996-04-30

Similar Documents

Publication Publication Date Title
DE69329274T2 (de) Hämatologisches Kontrollprodukt mit Leukozytenanalogen; und Methoden zu ihrer Herstellung und Anwendung
ES291678U (es) Sonda de dialisis principalmente prevista para su insercion en tejidos biologicos
NO943116L (no) Suspensjonsmedia for hematologisk sammensetning og fremgangsmåte for dens anvendelse
DE3586619T2 (de) Haematologische zusammensetzungen als referenz fuer drei populationen von leukocyten, verfahren zu deren herstellung und deren verwendung in ganzbluttestverfahren.
GB2072047B (en) Gas-permeable membrane method of making it and blood oxygenator based on the use thereof
DE3580973D1 (de) Geraet zur bestrahlung von blutteilen.
AU5817496A (en) Process for producing erythropoietin containing no animal pr oteins
EP0796040A4 (de) Verfahren und anordnung von beuteln zur konzentrierung weisser zellen
ATE80033T1 (de) Oxygenierter fluorkohlenstoff zur verwendung in intra-peritonialen perfusionen.
EP1466968A3 (de) Verfahren und Vorrichtung zur Einkapselung von biologisch aktiven Substanzen
WO1999059500A3 (en) Apparatus and methods for preparing an implantable graft
DE3872588T2 (de) Vereinfachtes verfahren zur herstellung von menschlichen lymphokinaktivierten killerzellen.
AU589582B2 (en) Control for blood gas analyzers and hemoglobin analysis
DE69631059D1 (de) Standard zur blutkontrolle
CA2014542A1 (en) Medical implant and method for the manufacture thereof
Alter et al. Control of the simian fetal hemoglobin switch at the progenitor cell level
Wilding et al. Use of pattern recognition technology for determination of the human differential leukocyte count
Dresch et al. Growth fraction of myelocytes in normal human granulopoiesis
SU605608A1 (ru) Способ исследовани ветвей магистральных кровеносных сосудов
SU1674806A1 (ru) Способ определени механической резистентности эритроцитов крови
CA2159005A1 (en) Method and apparatus for encapsulation of biologically-active substances in cells
EP0778027A3 (de) Verwendung von Kieselerde zur Herstellung von Arzneimitteln
Petroushin Simulation of emotions by means of music
Semenzato et al. T cells in chronic lymphatic leukaemia
Darbre Haemoglobin synthesis in CFU‐E‐derived erythroid colonies during sheep ontogeny

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: COULTER INTERNATIONAL CORP., MIAMI, FLA., US

R071 Expiry of right

Ref document number: 628167

Country of ref document: EP